for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Elsevier   (Total: 3175 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 3175 Journals sorted alphabetically
A Practical Logic of Cognitive Systems     Full-text available via subscription   (Followers: 9)
AASRI Procedia     Open Access   (Followers: 14)
Academic Pediatrics     Hybrid Journal   (Followers: 28, SJR: 1.402, h-index: 51)
Academic Radiology     Hybrid Journal   (Followers: 22, SJR: 1.008, h-index: 75)
Accident Analysis & Prevention     Partially Free   (Followers: 90, SJR: 1.109, h-index: 94)
Accounting Forum     Hybrid Journal   (Followers: 25, SJR: 0.612, h-index: 27)
Accounting, Organizations and Society     Hybrid Journal   (Followers: 33, SJR: 2.515, h-index: 90)
Achievements in the Life Sciences     Open Access   (Followers: 5)
Acta Anaesthesiologica Taiwanica     Open Access   (Followers: 6, SJR: 0.338, h-index: 19)
Acta Astronautica     Hybrid Journal   (Followers: 379, SJR: 0.726, h-index: 43)
Acta Automatica Sinica     Full-text available via subscription   (Followers: 2)
Acta Biomaterialia     Hybrid Journal   (Followers: 27, SJR: 2.02, h-index: 104)
Acta Colombiana de Cuidado Intensivo     Full-text available via subscription   (Followers: 2)
Acta de Investigación Psicológica     Open Access   (Followers: 3)
Acta Ecologica Sinica     Open Access   (Followers: 8, SJR: 0.172, h-index: 29)
Acta Haematologica Polonica     Free   (Followers: 1, SJR: 0.123, h-index: 8)
Acta Histochemica     Hybrid Journal   (Followers: 3, SJR: 0.604, h-index: 38)
Acta Materialia     Hybrid Journal   (Followers: 238, SJR: 3.683, h-index: 202)
Acta Mathematica Scientia     Full-text available via subscription   (Followers: 5, SJR: 0.615, h-index: 21)
Acta Mechanica Solida Sinica     Full-text available via subscription   (Followers: 9, SJR: 0.442, h-index: 21)
Acta Oecologica     Hybrid Journal   (Followers: 10, SJR: 0.915, h-index: 53)
Acta Otorrinolaringologica (English Edition)     Full-text available via subscription  
Acta Otorrinolaringológica Española     Full-text available via subscription   (Followers: 2, SJR: 0.311, h-index: 16)
Acta Pharmaceutica Sinica B     Open Access   (Followers: 1)
Acta Poética     Open Access   (Followers: 4)
Acta Psychologica     Hybrid Journal   (Followers: 25, SJR: 1.365, h-index: 73)
Acta Sociológica     Open Access  
Acta Tropica     Hybrid Journal   (Followers: 6, SJR: 1.059, h-index: 77)
Acta Urológica Portuguesa     Open Access  
Actas Dermo-Sifiliograficas     Full-text available via subscription   (Followers: 3)
Actas Dermo-Sifiliográficas (English Edition)     Full-text available via subscription   (Followers: 2)
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 3, SJR: 0.383, h-index: 19)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 1)
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 6, SJR: 0.141, h-index: 3)
Actualites Pharmaceutiques Hospitalieres     Full-text available via subscription   (Followers: 3, SJR: 0.112, h-index: 2)
Acupuncture and Related Therapies     Hybrid Journal   (Followers: 6)
Acute Pain     Full-text available via subscription   (Followers: 14)
Ad Hoc Networks     Hybrid Journal   (Followers: 11, SJR: 0.967, h-index: 57)
Addictive Behaviors     Hybrid Journal   (Followers: 15, SJR: 1.514, h-index: 92)
Addictive Behaviors Reports     Open Access   (Followers: 7)
Additive Manufacturing     Hybrid Journal   (Followers: 9, SJR: 1.039, h-index: 5)
Additives for Polymers     Full-text available via subscription   (Followers: 22)
Advanced Cement Based Materials     Full-text available via subscription   (Followers: 3)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 131, SJR: 5.2, h-index: 222)
Advanced Engineering Informatics     Hybrid Journal   (Followers: 11, SJR: 1.265, h-index: 53)
Advanced Powder Technology     Hybrid Journal   (Followers: 16, SJR: 0.739, h-index: 33)
Advances in Accounting     Hybrid Journal   (Followers: 8, SJR: 0.299, h-index: 15)
Advances in Agronomy     Full-text available via subscription   (Followers: 12, SJR: 2.071, h-index: 82)
Advances in Anesthesia     Full-text available via subscription   (Followers: 27, SJR: 0.169, h-index: 4)
Advances in Antiviral Drug Design     Full-text available via subscription   (Followers: 2)
Advances in Applied Mathematics     Full-text available via subscription   (Followers: 10, SJR: 1.054, h-index: 35)
Advances in Applied Mechanics     Full-text available via subscription   (Followers: 10, SJR: 0.801, h-index: 26)
Advances in Applied Microbiology     Full-text available via subscription   (Followers: 22, SJR: 1.286, h-index: 49)
Advances In Atomic, Molecular, and Optical Physics     Full-text available via subscription   (Followers: 14, SJR: 3.31, h-index: 42)
Advances in Biological Regulation     Hybrid Journal   (Followers: 4, SJR: 2.277, h-index: 43)
Advances in Botanical Research     Full-text available via subscription   (Followers: 2, SJR: 0.619, h-index: 48)
Advances in Cancer Research     Full-text available via subscription   (Followers: 28, SJR: 2.215, h-index: 78)
Advances in Carbohydrate Chemistry and Biochemistry     Full-text available via subscription   (Followers: 7, SJR: 0.9, h-index: 30)
Advances in Catalysis     Full-text available via subscription   (Followers: 5, SJR: 2.139, h-index: 42)
Advances in Cell Aging and Gerontology     Full-text available via subscription   (Followers: 3)
Advances in Cellular and Molecular Biology of Membranes and Organelles     Full-text available via subscription   (Followers: 12)
Advances in Chemical Engineering     Full-text available via subscription   (Followers: 27, SJR: 0.183, h-index: 23)
Advances in Child Development and Behavior     Full-text available via subscription   (Followers: 10, SJR: 0.665, h-index: 29)
Advances in Chronic Kidney Disease     Full-text available via subscription   (Followers: 10, SJR: 1.268, h-index: 45)
Advances in Clinical Chemistry     Full-text available via subscription   (Followers: 28, SJR: 0.938, h-index: 33)
Advances in Colloid and Interface Science     Full-text available via subscription   (Followers: 19, SJR: 2.314, h-index: 130)
Advances in Computers     Full-text available via subscription   (Followers: 14, SJR: 0.223, h-index: 22)
Advances in Dermatology     Full-text available via subscription   (Followers: 14)
Advances in Developmental Biology     Full-text available via subscription   (Followers: 10)
Advances in Digestive Medicine     Open Access   (Followers: 8)
Advances in DNA Sequence-Specific Agents     Full-text available via subscription   (Followers: 5)
Advances in Drug Research     Full-text available via subscription   (Followers: 21)
Advances in Ecological Research     Full-text available via subscription   (Followers: 42, SJR: 3.25, h-index: 43)
Advances in Engineering Software     Hybrid Journal   (Followers: 27, SJR: 0.486, h-index: 10)
Advances in Experimental Biology     Full-text available via subscription   (Followers: 6)
Advances in Experimental Social Psychology     Full-text available via subscription   (Followers: 42, SJR: 5.465, h-index: 64)
Advances in Exploration Geophysics     Full-text available via subscription   (Followers: 1)
Advances in Fluorine Science     Full-text available via subscription   (Followers: 7)
Advances in Food and Nutrition Research     Full-text available via subscription   (Followers: 53, SJR: 0.674, h-index: 38)
Advances in Fuel Cells     Full-text available via subscription   (Followers: 15)
Advances in Genetics     Full-text available via subscription   (Followers: 15, SJR: 2.558, h-index: 54)
Advances in Genome Biology     Full-text available via subscription   (Followers: 7)
Advances in Geophysics     Full-text available via subscription   (Followers: 6, SJR: 2.325, h-index: 20)
Advances in Heat Transfer     Full-text available via subscription   (Followers: 21, SJR: 0.906, h-index: 24)
Advances in Heterocyclic Chemistry     Full-text available via subscription   (Followers: 9, SJR: 0.497, h-index: 31)
Advances in Human Factors/Ergonomics     Full-text available via subscription   (Followers: 23)
Advances in Imaging and Electron Physics     Full-text available via subscription   (Followers: 2, SJR: 0.396, h-index: 27)
Advances in Immunology     Full-text available via subscription   (Followers: 36, SJR: 4.152, h-index: 85)
Advances in Inorganic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 1.132, h-index: 42)
Advances in Insect Physiology     Full-text available via subscription   (Followers: 2, SJR: 1.274, h-index: 27)
Advances in Integrative Medicine     Hybrid Journal   (Followers: 6)
Advances in Intl. Accounting     Full-text available via subscription   (Followers: 3)
Advances in Life Course Research     Hybrid Journal   (Followers: 8, SJR: 0.764, h-index: 15)
Advances in Lipobiology     Full-text available via subscription   (Followers: 1)
Advances in Magnetic and Optical Resonance     Full-text available via subscription   (Followers: 9)
Advances in Marine Biology     Full-text available via subscription   (Followers: 14, SJR: 1.645, h-index: 45)
Advances in Mathematics     Full-text available via subscription   (Followers: 10, SJR: 3.261, h-index: 65)
Advances in Medical Sciences     Hybrid Journal   (Followers: 6, SJR: 0.489, h-index: 25)
Advances in Medicinal Chemistry     Full-text available via subscription   (Followers: 5)
Advances in Microbial Physiology     Full-text available via subscription   (Followers: 4, SJR: 1.44, h-index: 51)
Advances in Molecular and Cell Biology     Full-text available via subscription   (Followers: 21)
Advances in Molecular and Cellular Endocrinology     Full-text available via subscription   (Followers: 8)
Advances in Molecular Toxicology     Full-text available via subscription   (Followers: 7, SJR: 0.324, h-index: 8)
Advances in Nanoporous Materials     Full-text available via subscription   (Followers: 3)
Advances in Oncobiology     Full-text available via subscription   (Followers: 1)
Advances in Organ Biology     Full-text available via subscription   (Followers: 1)
Advances in Organometallic Chemistry     Full-text available via subscription   (Followers: 15, SJR: 2.885, h-index: 45)
Advances in Parallel Computing     Full-text available via subscription   (Followers: 6, SJR: 0.148, h-index: 11)
Advances in Parasitology     Full-text available via subscription   (Followers: 5, SJR: 2.37, h-index: 73)
Advances in Pediatrics     Full-text available via subscription   (Followers: 24, SJR: 0.4, h-index: 28)
Advances in Pharmaceutical Sciences     Full-text available via subscription   (Followers: 10)
Advances in Pharmacology     Full-text available via subscription   (Followers: 15, SJR: 1.718, h-index: 58)
Advances in Physical Organic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 0.384, h-index: 26)
Advances in Phytomedicine     Full-text available via subscription  
Advances in Planar Lipid Bilayers and Liposomes     Full-text available via subscription   (Followers: 3, SJR: 0.248, h-index: 11)
Advances in Plant Biochemistry and Molecular Biology     Full-text available via subscription   (Followers: 7)
Advances in Plant Pathology     Full-text available via subscription   (Followers: 5)
Advances in Porous Media     Full-text available via subscription   (Followers: 5)
Advances in Protein Chemistry     Full-text available via subscription   (Followers: 17)
Advances in Protein Chemistry and Structural Biology     Full-text available via subscription   (Followers: 18, SJR: 1.5, h-index: 62)
Advances in Psychology     Full-text available via subscription   (Followers: 59)
Advances in Quantum Chemistry     Full-text available via subscription   (Followers: 6, SJR: 0.478, h-index: 32)
Advances in Radiation Oncology     Open Access  
Advances in Small Animal Medicine and Surgery     Hybrid Journal   (Followers: 3, SJR: 0.1, h-index: 2)
Advances in Space Biology and Medicine     Full-text available via subscription   (Followers: 5)
Advances in Space Research     Full-text available via subscription   (Followers: 377, SJR: 0.606, h-index: 65)
Advances in Structural Biology     Full-text available via subscription   (Followers: 5)
Advances in Surgery     Full-text available via subscription   (Followers: 9, SJR: 0.823, h-index: 27)
Advances in the Study of Behavior     Full-text available via subscription   (Followers: 29, SJR: 1.321, h-index: 56)
Advances in Veterinary Medicine     Full-text available via subscription   (Followers: 17)
Advances in Veterinary Science and Comparative Medicine     Full-text available via subscription   (Followers: 13)
Advances in Virus Research     Full-text available via subscription   (Followers: 5, SJR: 1.878, h-index: 68)
Advances in Water Resources     Hybrid Journal   (Followers: 46, SJR: 2.408, h-index: 94)
Aeolian Research     Hybrid Journal   (Followers: 6, SJR: 0.973, h-index: 22)
Aerospace Science and Technology     Hybrid Journal   (Followers: 334, SJR: 0.816, h-index: 49)
AEU - Intl. J. of Electronics and Communications     Hybrid Journal   (Followers: 8, SJR: 0.318, h-index: 36)
African J. of Emergency Medicine     Open Access   (Followers: 6, SJR: 0.344, h-index: 6)
Ageing Research Reviews     Hybrid Journal   (Followers: 9, SJR: 3.289, h-index: 78)
Aggression and Violent Behavior     Hybrid Journal   (Followers: 430, SJR: 1.385, h-index: 72)
Agri Gene     Hybrid Journal  
Agricultural and Forest Meteorology     Hybrid Journal   (Followers: 15, SJR: 2.18, h-index: 116)
Agricultural Systems     Hybrid Journal   (Followers: 31, SJR: 1.275, h-index: 74)
Agricultural Water Management     Hybrid Journal   (Followers: 43, SJR: 1.546, h-index: 79)
Agriculture and Agricultural Science Procedia     Open Access   (Followers: 1)
Agriculture and Natural Resources     Open Access   (Followers: 2)
Agriculture, Ecosystems & Environment     Hybrid Journal   (Followers: 56, SJR: 1.879, h-index: 120)
Ain Shams Engineering J.     Open Access   (Followers: 5, SJR: 0.434, h-index: 14)
Air Medical J.     Hybrid Journal   (Followers: 6, SJR: 0.234, h-index: 18)
AKCE Intl. J. of Graphs and Combinatorics     Open Access   (SJR: 0.285, h-index: 3)
Alcohol     Hybrid Journal   (Followers: 11, SJR: 0.922, h-index: 66)
Alcoholism and Drug Addiction     Open Access   (Followers: 9)
Alergologia Polska : Polish J. of Allergology     Full-text available via subscription   (Followers: 1)
Alexandria Engineering J.     Open Access   (Followers: 1, SJR: 0.436, h-index: 12)
Alexandria J. of Medicine     Open Access   (Followers: 1)
Algal Research     Partially Free   (Followers: 9, SJR: 2.05, h-index: 20)
Alkaloids: Chemical and Biological Perspectives     Full-text available via subscription   (Followers: 2)
Allergologia et Immunopathologia     Full-text available via subscription   (Followers: 1, SJR: 0.46, h-index: 29)
Allergology Intl.     Open Access   (Followers: 5, SJR: 0.776, h-index: 35)
Alpha Omegan     Full-text available via subscription   (SJR: 0.121, h-index: 9)
ALTER - European J. of Disability Research / Revue Européenne de Recherche sur le Handicap     Full-text available via subscription   (Followers: 9, SJR: 0.158, h-index: 9)
Alzheimer's & Dementia     Hybrid Journal   (Followers: 48, SJR: 4.289, h-index: 64)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring     Open Access   (Followers: 4)
Alzheimer's & Dementia: Translational Research & Clinical Interventions     Open Access   (Followers: 4)
Ambulatory Pediatrics     Hybrid Journal   (Followers: 6)
American Heart J.     Hybrid Journal   (Followers: 50, SJR: 3.157, h-index: 153)
American J. of Cardiology     Hybrid Journal   (Followers: 50, SJR: 2.063, h-index: 186)
American J. of Emergency Medicine     Hybrid Journal   (Followers: 43, SJR: 0.574, h-index: 65)
American J. of Geriatric Pharmacotherapy     Full-text available via subscription   (Followers: 10, SJR: 1.091, h-index: 45)
American J. of Geriatric Psychiatry     Hybrid Journal   (Followers: 14, SJR: 1.653, h-index: 93)
American J. of Human Genetics     Hybrid Journal   (Followers: 31, SJR: 8.769, h-index: 256)
American J. of Infection Control     Hybrid Journal   (Followers: 26, SJR: 1.259, h-index: 81)
American J. of Kidney Diseases     Hybrid Journal   (Followers: 32, SJR: 2.313, h-index: 172)
American J. of Medicine     Hybrid Journal   (Followers: 42, SJR: 2.023, h-index: 189)
American J. of Medicine Supplements     Full-text available via subscription   (Followers: 3)
American J. of Obstetrics and Gynecology     Hybrid Journal   (Followers: 191, SJR: 2.255, h-index: 171)
American J. of Ophthalmology     Hybrid Journal   (Followers: 62, SJR: 2.803, h-index: 148)
American J. of Ophthalmology Case Reports     Open Access   (Followers: 6)
American J. of Orthodontics and Dentofacial Orthopedics     Full-text available via subscription   (Followers: 6, SJR: 1.249, h-index: 88)
American J. of Otolaryngology     Hybrid Journal   (Followers: 25, SJR: 0.59, h-index: 45)
American J. of Pathology     Hybrid Journal   (Followers: 27, SJR: 2.653, h-index: 228)
American J. of Preventive Medicine     Hybrid Journal   (Followers: 27, SJR: 2.764, h-index: 154)
American J. of Surgery     Hybrid Journal   (Followers: 37, SJR: 1.286, h-index: 125)
American J. of the Medical Sciences     Hybrid Journal   (Followers: 12, SJR: 0.653, h-index: 70)
Ampersand : An Intl. J. of General and Applied Linguistics     Open Access   (Followers: 6)
Anaerobe     Hybrid Journal   (Followers: 4, SJR: 1.066, h-index: 51)
Anaesthesia & Intensive Care Medicine     Full-text available via subscription   (Followers: 61, SJR: 0.124, h-index: 9)
Anaesthesia Critical Care & Pain Medicine     Full-text available via subscription   (Followers: 14)
Anales de Cirugia Vascular     Full-text available via subscription  
Anales de Pediatría     Full-text available via subscription   (Followers: 2, SJR: 0.209, h-index: 27)
Anales de Pediatría (English Edition)     Full-text available via subscription  
Anales de Pediatría Continuada     Full-text available via subscription   (SJR: 0.104, h-index: 3)
Analytic Methods in Accident Research     Hybrid Journal   (Followers: 4, SJR: 2.577, h-index: 7)
Analytica Chimica Acta     Hybrid Journal   (Followers: 39, SJR: 1.548, h-index: 152)
Analytical Biochemistry     Hybrid Journal   (Followers: 166, SJR: 0.725, h-index: 154)
Analytical Chemistry Research     Open Access   (Followers: 10, SJR: 0.18, h-index: 2)
Analytical Spectroscopy Library     Full-text available via subscription   (Followers: 11)
Anesthésie & Réanimation     Full-text available via subscription   (Followers: 1)
Anesthesiology Clinics     Full-text available via subscription   (Followers: 22, SJR: 0.421, h-index: 40)
Angiología     Full-text available via subscription   (SJR: 0.124, h-index: 9)
Angiologia e Cirurgia Vascular     Open Access   (Followers: 1)

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Journal Cover American Journal of Kidney Diseases
  [SJR: 2.313]   [H-I: 172]   [32 followers]  Follow
    
   Hybrid Journal Hybrid journal (It can contain Open Access articles)
   ISSN (Print) 0272-6386 - ISSN (Online) 1523-6838
   Published by Elsevier Homepage  [3175 journals]
  • Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking
    • Authors: Perry Formanek; Elizabeth Salisbury-Afshar Majid Afshar
      Abstract: Publication date: Available online 13 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Perry Formanek, Elizabeth Salisbury-Afshar, Majid Afshar
      Among the many adverse effects of tobacco exposure is the increased risk for progression of kidney disease. Individuals with chronic kidney disease (CKD), who already face increased cardiovascular event rates compared to the general population, are at even greater risk if they smoke. Despite these risks and the increased focus on smoking cessation in the general population in recent years, national guidelines have not specifically targeted individuals with CKD. There are similarly sparse data specific to individuals with CKD regarding the safety and efficacy of evidence-based smoking cessation modalities. This review aims to identify the risks of nicotine dependence in individuals with CKD and the potential benefits of smoking cessation; discuss current strategies for smoking cessation, including behavioral and pharmacologic therapies such as varenicline; and extrapolate these interventions to the unique challenges of this population. Much of the data presented stem from evidence for the general population but are described with additional consideration in dosing of nicotine replacement therapy, as well as non-nicotine pharmacotherapy and treatment modality for individuals with CKD.

      PubDate: 2018-04-15T16:37:45Z
       
  • CKD and ESRD in US Hispanics
    • Authors: Nisa Desai; Claudia Lora James Lash Ana Ricardo
      Abstract: Publication date: Available online 13 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Nisa Desai, Claudia M. Lora, James P. Lash, Ana C. Ricardo
      Hispanics are the largest racial/ethnic minority group in the United States, and they experience a substantial burden of kidney disease. Although the prevalence of chronic kidney disease (CKD) is similar or slightly lower in Hispanics than non-Hispanic whites, the age- and sex-adjusted prevalence rate of end-stage renal disease is almost 50% higher in Hispanics compared with non-Hispanic whites. This has been attributed in part to faster CKD progression among Hispanics. Furthermore, Hispanic ethnicity has been associated with a greater prevalence of cardiovascular disease risk factors, including obesity and diabetes, as well as CKD-related complications. Despite their less favorable socioeconomic status, which often leads to limited access to quality health care, and their high comorbid condition burden, the risk for mortality among Hispanics appears to be lower than for non-Hispanic whites. This survival paradox has been attributed to a complex interplay between sociocultural and psychosocial factors, as well as other factors. Future research should focus on evaluating the long-term impact of these factors on patient-centered and clinical outcomes. National policies are needed to improve access to and quality of health care among Hispanics with CKD.

      PubDate: 2018-04-15T16:37:45Z
       
  • Genetic Testing in Clinical Settings
    • Authors: Nora Franceschini; Amber Frick Jeffrey Kopp
      Abstract: Publication date: Available online 11 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Nora Franceschini, Amber Frick, Jeffrey B. Kopp
      Genetic testing is used for screening, diagnosis, and prognosis of diseases consistent with a genetic cause and to guide drug therapy to improve drug efficacy and avoid adverse effects (pharmacogenomics). This In Practice review aims to inform about DNA-related genetic test availability, interpretation, and recommended clinical actions based on results using evidence from clinical guidelines, when available. We discuss challenges that limit the widespread use of genetic information in the clinical care setting, including a small number of actionable genetic variants with strong evidence of clinical validity and utility, and the need for improving the health literacy of health care providers and the public, including for direct-to-consumer tests. Ethical, legal, and social issues and incidental findings also need to be addressed. Because our understanding of genetic factors associated with disease and drug response is rapidly increasing and new genetic tests are being developed that could be adopted by clinicians in the short term, we also provide extensive resources for information and education on genetic testing.

      PubDate: 2018-04-12T16:33:07Z
       
  • Dietary Management of Hyperphosphatemia
    • Authors: Shivam Joshi; Vishnu Potluri Siddharth Shah
      Abstract: Publication date: Available online 11 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Shivam Joshi, Vishnu Potluri, Siddharth Shah


      PubDate: 2018-04-12T16:33:07Z
       
  • Estimating Time to ESRD in Children With CKD
    • Authors: Susan Furth; Chris Pierce Wun Fung Hui Colin White Craig
      Abstract: Publication date: Available online 10 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Susan L. Furth, Chris Pierce, Wun Fung Hui, Colin A. White, Craig S. Wong, Franz Schaefer, Elke Wühl, Alison G. Abraham, Bradley A. Warady
      Rationale & Objective The KDIGO (Kidney Disease: Improving Global Outcomes) guideline for chronic kidney disease (CKD) presented an international classification system that ranks patients’ risk for CKD progression. Few data for children informed guideline development. Study Design Observational cohort study. Settings & Participants Children aged 1 to 18 years enrolled in the North American Chronic Kidney Disease in Children (CKiD) cohort study and the European Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) trial. Predictor Level of estimated glomerular filtration rate (eGFR) and proteinuria (urine protein-creatinine ratio [UPCR]) at study entry. Outcome A composite event of renal replacement therapy, 50% reduction in eGFR, or eGFR<15mL/min/1.73m2. eGFR was estimated using the CKiD-derived “bedside” equation. Analytical Approach Accelerated failure time models of the composite outcome using a conventional generalized gamma distribution. Likelihood ratio statistics of nested models were used to amalgamate levels of similar risk. Results Among 1,232 children, median age was 12 (IQR, 8-15) years, median eGFR was 47 (IQR, 33-62) mL/min/1.73m2, 60% were males, and 13% had UPCRs>2.0mg/mg at study entry. 6 ordered stages with varying combinations of eGFR categories (60-89, 45-59, 30-44, and 15-29mL/min/1.73m2) and UPCR categories (<0.5, 0.5-2.0, and >2.0mg/mg) described the risk continuum. Median times to event ranged from longer than 10 years for eGFRs of 45 to 90mL/min/1.73m2 and UPCRs<0.5mg/mg to 0.8 years for eGFRs of 15 to 30mL/min/1.73m2 and UPCRs>2mg/mg. Children with glomerular disease were estimated to have a 43% shorter time to event than children with nonglomerular disease. Cross-validation demonstrated risk patterns that were consistent across the 10 subsample validation models. Limitations Observational study, used cross-validation rather than external validation. Conclusions CKD staged by level of eGFR and proteinuria characterizes the timeline of progression and can guide management strategies in children.

      PubDate: 2018-04-12T16:33:07Z
       
  • A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year
           Mortality Among Individuals Receiving Maintenance Hemodialysis
    • Authors: Magdalene Assimon; Alan Brookhart Jason Fine Gerardo Heiss Bradley Layton
      Abstract: Publication date: Available online 10 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Magdalene M. Assimon, M. Alan Brookhart, Jason P. Fine, Gerardo Heiss, J. Bradley Layton, Jennifer E. Flythe
      Background Carvedilol and metoprolol are the β-blockers most commonly prescribed to US hemodialysis patients, accounting for ∼80% of β-blocker prescriptions. Despite well-established pharmacologic and pharmacokinetic differences between the 2 medications, little is known about their relative safety and efficacy in the hemodialysis population. Study Design A retrospective cohort study using a new-user design. Setting & Participants Medicare-enrolled hemodialysis patients treated at a large US dialysis organization who initiated carvedilol or metoprolol therapy from January 1, 2007, through December 30, 2012. Predictor Carvedilol versus metoprolol initiation. Outcomes All-cause mortality, cardiovascular mortality, and intradialytic hypotension (systolic blood pressure decrease ≥ 20mmHg during hemodialysis plus intradialytic saline solution administration) during a 1-year follow-up period. Measurements Survival models were used to estimate HRs and 95% CIs in mortality analyses. Poisson regression was used to estimate incidence rate ratios (IRRs) and 95% CIs in intradialytic hypotension analyses. Inverse probability of treatment weighting was used to adjust for several demographic, clinical, laboratory, and dialysis treatment covariates in all analyses. Results 27,064 individuals receiving maintenance hemodialysis were included: 9,558 (35.3%) carvedilol initiators and 17,506 (64.7%) metoprolol initiators. Carvedilol (vs metoprolol) initiation was associated with greater all-cause (adjusted HR, 1.08; 95% CI, 1.02-1.16) and cardiovascular mortality (adjusted HR, 1.18; 95% CI, 1.08-1.29). In subgroup analyses, similar associations were observed among patients with hypertension, atrial fibrillation, heart failure, and a recent myocardial infarction, the main cardiovascular indications for β-blocker therapy. During follow-up, carvedilol (vs metoprolol) initiators had a higher rate of intradialytic hypotension (adjusted IRR, 1.10; 95% CI, 1.09-1.11). Limitations Residual confounding may exist. Conclusions Relative to metoprolol initiation, carvedilol initiation was associated with higher 1-year all-cause and cardiovascular mortality. One potential mechanism for these findings may be the increased occurrence of intradialytic hypotension after carvedilol (vs metoprolol) initiation.

      PubDate: 2018-04-12T16:33:07Z
       
  • Delivering a “New Deal” of Kidney Health Opportunities to Improve
           Outcomes Within the Veterans Health Administration
    • Authors: Susan Crowley; Katherine Murphy
      Abstract: Publication date: Available online 5 April 2018
      Source:American Journal of Kidney Diseases
      Author(s): Susan T. Crowley, Katherine Murphy
      Just as the “New Deal” aimed to elevate the “forgotten man” of the Great Depression through governmental relief and reform, so does the Department of Veterans Affairs (VA) health care system aim to improve the health of veterans with the invisible illness of chronic kidney disease through a concerted series of health care delivery reforms. Augmenting its primary care platform with advances in informatics and health service delivery initiatives targeting kidney disease, the VA is changing how nephrology care is provided to veterans with the goal of optimized population kidney health. As the largest provider of kidney health services in the country, the VA offers an instructive case study of the value of comprehensive health care coverage for people with chronic kidney disease. Recent reports of kidney health outcomes among veterans support the benefit of the VA’s integrated health care delivery system. Suggestions to optimize veterans’ kidney health further may be equally applicable to other health systems caring for people afflicted with kidney disease.

      PubDate: 2018-04-12T16:33:07Z
       
  • A Timely Evaluation of the Psychometric Properties of the KDQOL-36
    • Authors: Kelly Chong; Larissa Myaskovsky Mark Unruh
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Kelly Chong, Larissa Myaskovsky, Mark Unruh


      PubDate: 2018-04-12T16:33:07Z
       
  • Lessons From International Differences in Vascular Access Practices and
           Outcomes
    • Authors: Michael Allon
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Michael Allon


      PubDate: 2018-04-12T16:33:07Z
       
  • Rising Peritoneal Dialysis Tide May Still Leave Some Patients Behind
    • Authors: Marc Turenne
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Marc Turenne


      PubDate: 2018-04-12T16:33:07Z
       
  • A New Treatment Option for Highly Sensitized Patients Awaiting Kidney
           Transplantation
    • Authors: Enver Akalin
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Enver Akalin


      PubDate: 2018-04-12T16:33:07Z
       
  • Health Insurance and the Use of Peritoneal Dialysis in the United States
    • Authors: Jose Perez; Zhao Samaya Qureshi Wolfgang Winkelmayer Kevin Erickson
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Jose J. Perez, Bo Zhao, Samaya Qureshi, Wolfgang C. Winkelmayer, Kevin F. Erickson
      Background Many patients in the United States have limited or no health insurance at the time they develop end-stage renal disease (ESRD). We examined whether health insurance limitations affected the likelihood of peritoneal dialysis (PD) use. Study Design Retrospective cohort analysis of patients from the US Renal Data System initiating dialysis therapy in 2006 through 2012. Setting & Participants We identified socioeconomically similar groups of patients to examine the association between health insurance and PD use. Patients aged 60 to 64 years with “limited insurance” (defined as having Medicaid or no insurance) at ESRD onset were compared with patients aged 66 to 70 years who were dually eligible for Medicare and Medicaid at ESRD onset. Predictor Type of insurance coverage at ESRD onset. Outcomes The likelihoods of receiving PD before dialysis month 4, when all patients qualified for Medicare due to ESRD, and of switching to PD therapy following receipt of Medicare. Results After adjusting for observable patient and geographic differences, patients with limited insurance had an absolute 2.4% (95% CI, 1.1%-3.7%) lower probability of PD use by dialysis month 4 compared with patients with Medicare at ESRD onset. The association between insurance and PD use reversed when patients became Medicare eligible; patients with limited insurance had a 3-fold higher rate of switching to PD therapy between months 4 and 12 of dialysis (HR, 2.9; 95% CI, 1.8-4.6) compared with patients with Medicare at ESRD onset. Limitations Because this study was observational, there is a potential for bias from unmeasured patient-level factors. Conclusions Despite Medicare’s policy of covering patients in the month that they initiate PD therapy, insurance limitations remain a barrier to PD use for many patients. Educating providers about Medicare reimbursement policy and expanding access to pre-ESRD education and training may help overcome these barriers.
      Graphical abstract image

      PubDate: 2018-04-12T16:33:07Z
       
  • Caring for Undocumented Immigrants With Kidney Disease
    • Authors: Rajeev Raghavan
      Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4
      Author(s): Rajeev Raghavan
      The care of dialysis-dependent undocumented immigrants exemplifies a problem at the crux of 2 US national agendas: immigration and health care reform. Undocumented immigrants represent 3% of the US population and 27% of the uninsured, and an estimated 6,500 individuals are dialysis dependent. With no uniform national policy, an estimated 30% to 50% of these individuals receive treatment only in life-threatening situations (emergent dialysis). Since 2005, about 400 undocumented immigrants have received a kidney transplant (>70% living). Although the Affordable Care Act specifically excluded noncitizens, its policies have indirectly allowed more than 200 individuals to purchase insurance from a health insurance exchange and transition from emergent to thrice-weekly hemodialysis. Under the Trump administration, uncertainties with health care plans, threats of deportation, and rescinding of policies such as sanctuary city status are bound to result in unforeseen challenges for this vulnerable population. Global variation in the care accessible to migrants, refugees, undocumented immigrants, and asylum seekers argues for the need for a framework to transform advocacy into public policy to improve the lives of patients with kidney disease worldwide. Access to nonemergent dialysis is humane and cost-effective; it deserves to be espoused and advocated by leading medical organizations.

      PubDate: 2018-04-12T16:33:07Z
       
  • Erratum Regarding “US Renal Data System 2017 Annual Data Report:
           Epidemiology of Kidney Disease in the United States” (Am J Kidney Dis.
           2018;71[3][suppl 1]:Svii,S1-S676)
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • National Kidney Foundation 2018 Spring Clinical Meeting Abstracts April
           10-14, 2018
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 1 Scelroderma Renal Crisis in Pregnancy with Features of HELLP Syndrome
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 2 Association of Sleep Apnea with Mortality in Chronic and End Stage
           Kidney Disease Patients
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 3 Emphysematous Pyelonephritis in A Renal Allograft Patient: A Case Report
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 4 Bilateral Renal Infarctions During the Use of Sumatriptan
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 5 Hypocalcemia and Bone Mineral Density Changes Following Denosumab
           Treatment in End-Stage Renal Disease Patients: A Meta-analysis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 6 Oxalosis Causing Acute Kidney Injury and Encephalopathy
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 7 Renal Failure Secondary to Post Traumatic Osteolysis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 8 Sometimes It's Not the Kidney
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 9 Female Sex Protects Against Mortality After an Episode of Acute Kidney
           Injury. (AKI)
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 10 Intrauterine Device-Associated Peritonitis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 11 The Case of the Pink Effluent: Are All Blood Leak Alarms an
           Emergency'
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 12 Nephro-Cutaneous Fistula in Dual Renal Allograft with Poly-Microbial
           Pyelonephritis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 13 Real Time Hemodynamic Assessment to Access Related Heart Failure
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 14 Cardiac Output Relates to Net Volume Balance with Intermittent or
           Continuous Hemodialysis and to Relative Intravascular Volume in Critical
           Illness
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 15 Complete Resolution of Nephrotic Syndrome with Membranous Nephropathy
           (MN) Following Curative Therapy for Triplenegative Breast Cancer (TNBC)
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 16 Immobilization Related Hypercalcemia Resistant to Denosumab but
           Responsive to Cinacalcet
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 17 Ebv Infection Can Cause Membranous Nephropathy'
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 18 Unique Case of Peritoneal Dialysis Peritonitis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 19 Perspectives on the Management of Malignant Pheochromocytoma with
           Widespread Metastasis
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 20 Lupus Podocytopathy in A Patient with Antiphospholipid Antibody
           Syndrome (APS): A Rare Pair
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 21 Sustained Virologic Response: Is it Enough for The Kidney'
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 22 Late-Onset Gross Hematuric AKI from IgAN
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 23 Non-Conventional Therapy of A Triple Acid Base Disorder
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 24 Diabetic Fibrillosis: An Unexpected Finding
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 25 Page Kidney and Decreased Renal Function Secondary to Renal Subcapsular
           Hematoma After Extracorporeal Shock Wave Lithotripsy (ESWL)
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 26 Nephrectomy: An Old Treatment for A Common Disease
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 27 AKI Due to Non Traumatic Rhabdomyolysis Secondary to Propofol; Time to
           Consider Alternatives to Sedation in Critically-Ill Patients
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 28 Failed Target Weight Attainment Associates with Short-Term Hospital
           Encounters Among Hemodialysis Patients
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 29 Oxacillin-Induced Hypomagnesemia
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 30 A Challenging Case of Class IV Lupus Nephritis with Necrotizing and
           Crescentic Glomerulonephritis Associated with Positive Anca (ANCA-NCGN)
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 31 Incidence and Risk Factors for Acute Kidney Injury in Diabetic
           Ketoacidosis, and Hyperosmolar Hyperglycemic State
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
  • 32 Catastrophic Anti-Phospholipid Syndrome: Is It A Transient Ischemic
           Attack of the Kidney'
    • Abstract: Publication date: April 2018
      Source:American Journal of Kidney Diseases, Volume 71, Issue 4


      PubDate: 2018-04-12T16:33:07Z
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.167.196.208
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-